These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9614517)

  • 1. Necrotising fasciitis as a complication of botulinum toxin injection.
    Latimer PR; Hodgkins PR; Vakalis AN; Butler RE; Evans AR; Zaki GA
    Eye (Lond); 1998; 12 ( Pt 1)():51-3. PubMed ID: 9614517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fournier's gangrene following botulinum toxin injection.
    Mallo-González N; López-Rodríguez R; Fentes DP; Campos-Franco J; Lado FL; Alende-Sixto MR
    Scand J Urol Nephrol; 2008; 42(3):301-3. PubMed ID: 18432537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Botulinum toxin--from threat to cure].
    Odergren T; Lennerstrand G; Lindestad PA; Hertegård S; Borg J
    Lakartidningen; 1996 Apr; 93(17):1619-24. PubMed ID: 8667769
    [No Abstract]   [Full Text] [Related]  

  • 4. [Blepharospasm: treatment with botulinum toxin].
    Barbosa ER; Silva HC; Haddad MS; Bittar MS
    Rev Hosp Clin Fac Med Sao Paulo; 1996; 51(6):220-3. PubMed ID: 9239894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum toxin increases tearing in patients with Sjögren's syndrome: a preliminary report.
    Spiera H; Asbell PA; Simpson DM
    J Rheumatol; 1997 Sep; 24(9):1842-3. PubMed ID: 9292815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum toxin in the treatment of paralytic strabismus and essential blepharospasm.
    Thomas R; Mathai A; Rajeev B; Sen S; Jacob P
    Indian J Ophthalmol; 1993 Oct; 41(3):121-4. PubMed ID: 8125543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of idiopathic blepharospasm with botulinum toxin A].
    Toczołowski J; Romaniuk W; Wróblewska E; Stelmasiak Z; Lewandowska-Furmanik M
    Klin Oczna; 1994 Mar; 96(3):95-6. PubMed ID: 8090009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iatrogenic botulism after botulinum toxin type A injections.
    Coban A; Matur Z; Hanagasi HA; Parman Y
    Clin Neuropharmacol; 2010 May; 33(3):158-60. PubMed ID: 20150804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of botulinum toxin in ophthalmology: current concepts and problems].
    Tapiero B; Robert PY; Adenis JP; Riss I
    J Fr Ophtalmol; 1997; 20(2):134-45. PubMed ID: 9099272
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of botulinum toxin injection for achalasia in Thai patients.
    Leelakusolvong S; Sinpeng T; Pongprasobchai S; Tanwandee T; Kachintorn U; Manatsathit S
    J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S67-72. PubMed ID: 17718248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical and psychological factors influencing the efficacy of botulinum toxin in the treatment of hemifacial spasm and blepharospasm].
    Burbaud P; Arnaud A; Burbaud A; Lagueny A
    J Fr Ophtalmol; 1995; 18(12):751-7. PubMed ID: 8745707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of botulinum toxic injection to treat excessive drooling in children with neurological conditions.
    Khan A; Pawar G
    W V Med J; 2005; 101(6):258-60. PubMed ID: 16625812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Botulinum toxin useful against writer's cramp].
    Kruisdijk JJ; Koelman JH; Ongerboer de Visser BW; de Haan RJ; Speelman JD
    Ned Tijdschr Geneeskd; 2009 Jan; 153(4):118-23. PubMed ID: 19348131
    [No Abstract]   [Full Text] [Related]  

  • 14. Human response to unintended intrathecal injection of botulinum toxin.
    Carroll I; Fischbein N; Barad M; Mackey S
    Pain Med; 2011 Jul; 12(7):1094-7. PubMed ID: 21627762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum toxin therapy for blepharospasm in the otolaryngology clinic.
    Lassen LF; Adams J
    ORL Head Neck Nurs; 1994; 12(3):12-3. PubMed ID: 8564763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BotB (botulinum toxin type B): evaluation of safety and tolerability in botulinum toxin type A-resistant cervical dystonia patients (preliminary study).
    Truong DD; Cullis PA; O'Brien CF; Koller M; Villegas TP; Wallace JD
    Mov Disord; 1997 Sep; 12(5):772-5. PubMed ID: 9380065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dose-response relationship in the treatment of cervical dystonia with botulinum toxin type A (AGN 191622)--a phase II study].
    Mezaki T; Kaji R; Kimura J; Mannen T
    No To Shinkei; 1995 Sep; 47(9):857-62. PubMed ID: 7546934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symptomatic improvement in achalasia after botulinum toxin injection of the lower esophageal sphincter.
    Fishman VM; Parkman HP; Schiano TD; Hills C; Dabezies MA; Cohen S; Fisher RS; Miller LS
    Am J Gastroenterol; 1996 Sep; 91(9):1724-30. PubMed ID: 8792688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment with botulinum toxin in blepharospasm].
    Grandas F
    Arch Neurobiol (Madr); 1991; 54(5):206-9. PubMed ID: 1804034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective study of esophageal botulinum toxin injection in high-risk achalasia patients.
    Gordon JM; Eaker EY
    Am J Gastroenterol; 1997 Oct; 92(10):1812-7. PubMed ID: 9382042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.